載入...
Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models
Baloxavir marboxil (BXM) is an orally available small molecule inhibitor of cap-dependent endonuclease (CEN), an essential enzyme in the initiation of mRNA synthesis of influenza viruses. In the present study, we evaluated the efficacy of BXM against influenza virus infection in mouse models. Single...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527232/ https://ncbi.nlm.nih.gov/pubmed/31107922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0217307 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|